ACHV ▲ +0.1% - Achieve Life Sciences, Inc.
$ACHV - Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
28-SEP-2026 08:30 AM ET
Share this post
More filings for $ACHV
ACHV ▼ -2.1% - Achieve Life Sciences, Inc.Sep 3, 2026ACHV - Achieve Life Sciences, Inc. - SEC Filing Update (17-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 18, 2026ACHV - Achieve Life Sciences, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026$ACHV SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026$ACHV SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026$ACHV SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 8, 2026
View full $ACHV filing history →💬 Comments
Loading comments…
Leave a comment